Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConvertible DebtCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNon-Current DebtNotes PayablesOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

SRx Health Solutions (SRXH) Preferred Shares (2016 - 2019)

SRx Health Solutions' Preferred Shares history spans 9 years, with the latest figure at $13.0 million for Q3 2019.

  • For Q3 2019, Preferred Shares changed N/A year-over-year to $13.0 million; the TTM value through Sep 2019 reached $13.0 million, changed N/A, while the annual FY2018 figure was $2000.0, N/A changed from the prior year.
  • Preferred Shares reached $13.0 million in Q3 2019 per SRXH's latest filing, roughly flat from $13.0 million in the prior quarter.
  • In the past five years, Preferred Shares ranged from a high of $13.0 million in Q2 2019 to a low of $1.0 in Q1 2015.
  • Average Preferred Shares over 5 years is $1.5 million, with a median of $1.0 recorded in 2015.
  • The largest YoY upside for Preferred Shares was 0.0% in 2015 against a maximum downside of 0.0% in 2015.
  • A 5-year view of Preferred Shares shows it stood at $1.0 in 2015, then changed by 0.0% to $1.0 in 2016, then changed by 0.0% to $1.0 in 2017, then changed by 0.0% to $1.0 in 2018, then soared by 1300699900.0% to $13.0 million in 2019.
  • Per Business Quant, the three most recent readings for SRXH's Preferred Shares are $13.0 million (Q3 2019), $13.0 million (Q2 2019), and $1.0 (Q3 2018).